Intermittent administration of a growth hormone secretagogue

Details Intermittent administration of a growth hormone secretagogue Intermittent administration of a growth hormone secretagogue

A - Human Necessities

61

K

A61K 31/437 (2006.01) A61K 9/22 (2006.01) A61K 9/52 (2006.01) A61K 45/08 (2006.01) A61P 3/04 (2006.01) A61P 19/10 (2006.01)

Patent

CA 2356058

The present invention relates to the intermittent administration of a growth hormone secretagogue to a patient. The hormone secretagogue is, for example, 2-amino- N-[2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro- pyrazolo[4,3-c]pyridin-5-yl)-1-(R)-benzyloxymethyl-2-oxo- ethyl]-isobutyramide or a pharmaceutically acceptable salt or prodrug thereof, or a pharmaceutically acceptable salt of the prodrug. The growth hormone secretagogue may be taken, for example, every 2, 3 or 4 days. By this way, unwanted effects associated with daily administration of the growth hormone secretagogue may be ameliorated.

Affiliated with

Also associated with

Rating

Intermittent administration of a growth hormone secretagogue does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intermittent administration of a growth hormone secretagogue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermittent administration of a growth hormone secretagogue will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1803049